2017 - Rare Disease Disorders and CNS Drug Development – Paving the Way for Precision Medicine

Join medical experts from Medpace’s neuroscience team as they explore:
The shifting clinical development landscape – Discussion of new genetic findings in Parkinson’s Disease, Dementia, and ALS, as well as the heritability of psychiatric disorders
The history of treatment of rare diseases with CNS manifestations – successes and failures
Operational lessons-learned in identifying, enrolling and retaining rare disease populations in clinical trials
New approaches to deliver disease specific targeted therapies to the CNS